- Home
- HQH vs QDEL Comparison
HQH vs QDEL Comparison
Compare HQH & QDEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | HQH | QDEL |
|---|---|---|
| Founded | 1986 | 1979 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Finance Companies | Medical Specialities |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 1.0B |
| IPO Year | N/A | 2022 |
Fundamental Metrics
Financial Performance| Metric | HQH | QDEL |
|---|---|---|
| Price | $18.34 | $16.58 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 4 |
| Target Price | N/A | ★ $32.75 |
| AVG Volume (30 Days) | 149.2K | ★ 1.6M |
| Earning Date | 01-01-0001 | 05-06-2026 |
| Dividend Yield | ★ 11.56% | N/A |
| EPS Growth | N/A | ★ 45.35 |
| EPS | ★ 1.09 | N/A |
| Revenue | N/A | ★ $2,730,200,000.00 |
| Revenue This Year | N/A | $3.51 |
| Revenue Next Year | N/A | $3.86 |
| P/E Ratio | $16.39 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $13.77 | $14.45 |
| 52 Week High | $20.46 | $37.24 |
Technical Indicators
Market Signals| Indicator | HQH | QDEL |
|---|---|---|
| Relative Strength Index (RSI) | 49.70 | 41.62 |
| Support Level | $17.70 | N/A |
| Resistance Level | $19.57 | $30.65 |
| Average True Range (ATR) | 0.47 | 1.21 |
| MACD | 0.03 | 0.27 |
| Stochastic Oscillator | 67.47 | 47.72 |
Price Performance
Historical ComparisonAbout HQH abrdn Healthcare Investors Shares of Beneficial Interest
abrdn Healthcare Investors Formerly Tekla Healthcare Investors is the United States based non-diversified closed-end management investment company. Its objective is to seek long-term capital appreciation by investing in securities of healthcare companies. In addition, the fund seeks to provide regular distribution of realized capital gains. The fund invests in the securities of public and private companies.
About QDEL QuidelOrtho Corporation
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry, and transfusion medicine, which helps clinicians and patients to make decisions across the globe. Geographically, the company has its presence in North America, EMEA, China, and Other countries. It generates the majority of its revenue from North America.